Assess whether to stop a model that increases alert volume without outcomes

SITUATION A model vendor claiming AUC that the local validation cannot reproduce put unexpected mortality case series in front of mortality-and-morbidity reviewer in a rural hospital with long transfer times. This Healthcare / Outcomes Review close is to stop a model from unexpected mortality case series, and the live options are Proceed under protocol, Pause the pathway, Escalate safety review.

DECISION Mortality-and-morbidity reviewer in a rural hospital with long transfer times must choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold using unexpected mortality case series after a model vendor claiming AUC that the local validation cannot reproduce.

HYPOTHESES TO TEST 1. Unexpected mortality case series reads as Proceed under protocol once a model vendor claiming AUC that the local validation cannot reproduce is maps to the same Healthcare population. 2. Unexpected mortality case series is closer to Pause the pathway after a model vendor claiming AUC that the local validation cannot reproduce; Proceed under protocol would over-claim this Outcomes Review extract. 3. Escalate safety review is still live in unexpected mortality case series for mortality-and-morbidity reviewer in a rural hospital with long transfer times. 4. Unexpected mortality case series is missing the fact mortality-and-morbidity reviewer needs after a model vendor claiming AUC that the local validation cannot reproduce; stop this Healthcare close.

ANALYSIS REQUIRED 1. Quantify who is harmed if unexpected mortality case series is wrong. 2. Separate a documented exception from an OCR-relevant gap in a rural hospital with long transfer times. 3. Validate clinical-outcome evidence and protocol steps in unexpected mortality case series after a model vendor claiming AUC that the local validation cannot reproduce. 4. For this Healthcare Outcomes Review file, read unexpected mortality case series against a model vendor claiming AUC that the local validation cannot reproduce and write the one fact that would move to stop a model for mortality-and-morbidity reviewer.

RECOMMENDATION Choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold on this Healthcare / Outcomes Review packet (unexpected mortality case series after a model vendor claiming AUC that the local validation cannot reproduce). If unexpected mortality case series cannot force a Healthcare label under Outcomes Review, stop. If unexpected mortality case series after a model vendor claiming AUC that the local validation cannot reproduce cannot support Proceed under protocol versus Pause the pathway on this Healthcare Outcomes Review close, mortality-and-morbidity reviewer must state the unresolved clinical or safety evidence requirement explicitly.